Wei Li

Research Associate Professor

  • 995 Citations
1991 …2023

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Wei Li is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

  • Research Output

    Anti-secretogranin III therapy of oxygen-induced retinopathy with optimal safety

    Tang, F., LeBlanc, M. E., Wang, W., Liang, D., Chen, P., Chou, T. H., Tian, H. & Li, W., Jan 1 2019, (Accepted/In press) In : Angiogenesis.

    Research output: Contribution to journalArticle

  • 1 Scopus citations

    Function-first ligandomics for ocular vascular research and drug target discovery

    Rong, X., Tian, H., Yang, L. & Li, W., May 1 2019, In : Experimental Eye Research. 182, p. 57-64 8 p.

    Research output: Contribution to journalShort survey

  • Secretogranin III as a novel target for the therapy of choroidal neovascularization

    LeBlanc, M. E., Wang, W., Ji, Y., Tian, H., Liu, D., Zhang, X. & Li, W., Apr 1 2019, In : Experimental Eye Research. 181, p. 120-126 7 p.

    Research output: Contribution to journalArticle

  • 1 Scopus citations

    Ligandomics: a paradigm shift in biological drug discovery

    Li, W., Pang, I. H., Pacheco, M. T. F. & Tian, H., Mar 1 2018, In : Drug Discovery Today. 23, 3, p. 636-643 8 p.

    Research output: Contribution to journalReview article

  • 6 Scopus citations

    Secretogranin III: a diabetic retinopathy-selective angiogenic factor

    Li, W., Webster, K. A., LeBlanc, M. E. & Tian, H., Feb 1 2018, In : Cellular and Molecular Life Sciences. 75, 4, p. 635-647 13 p.

    Research output: Contribution to journalReview article

  • 4 Scopus citations